tiprankstipranks
Advertisement
Advertisement

NVCT Stock Latest News

Nuvectis’ NXP800 Ovarian Cancer Trial Terminated: What Investors Should Watch Next
Company AnnouncementsNuvectis’ NXP800 Ovarian Cancer Trial Terminated: What Investors Should Watch Next
1d ago
NVCT
Nuvectis Pharma price target raised to $34 from $22 at Lucid Capital
PremiumThe Fly
Nuvectis Pharma price target raised to $34 from $22 at Lucid Capital
2d ago
NVCT
Nuvectis Pharma’s Heavy Reliance on Haisco Poses Major Operational and Geopolitical Risks
PremiumCompany Announcements
Nuvectis Pharma’s Heavy Reliance on Haisco Poses Major Operational and Geopolitical Risks
2d ago
NVCT
Nuvectis Pharma: Buy Rating Reiterated as Late-Stage Pipeline Expands and $39 Price Target Remains Unchanged
PremiumRatings
Nuvectis Pharma: Buy Rating Reiterated as Late-Stage Pipeline Expands and $39 Price Target Remains Unchanged
3d ago
NVCT
Nuvectis’ NXP100 Just Achieved the First Marketing Approval Ever for a Once-Daily Oral Factor B Inhibitor
PremiumTipRanks Newswire
Nuvectis’ NXP100 Just Achieved the First Marketing Approval Ever for a Once-Daily Oral Factor B Inhibitor
15d ago
NVS
CRNX
Pantginis Reiterates Buy on Nuvectis, Citing Ciprocopan Approval and Pipeline Diversification; Price Target Maintained at $39
PremiumRatingsPantginis Reiterates Buy on Nuvectis, Citing Ciprocopan Approval and Pipeline Diversification; Price Target Maintained at $39
15d ago
NVCT
Nuvectis Pharma receives marketing approval in China for ciprocopan
Premium
The Fly
Nuvectis Pharma receives marketing approval in China for ciprocopan
15d ago
NVCT
Nuvectis Pharma’s NXP900 Combo Trial Adds Fresh Momentum to NVCT in EGFR Lung Cancer
Premium
Company Announcements
Nuvectis Pharma’s NXP900 Combo Trial Adds Fresh Momentum to NVCT in EGFR Lung Cancer
29d ago
NVCT
The Billion-Dollar Pill: With NXP100, Nuvectis Pharma Just Staked Its Claim in the New Biotech Gold Rush
PremiumTipRanks Newswire
The Billion-Dollar Pill: With NXP100, Nuvectis Pharma Just Staked Its Claim in the New Biotech Gold Rush
29d ago
LLY
ABBV
Nuvectis Pharma price target raised to $33 from $20 at Roth Capital
PremiumThe Fly
Nuvectis Pharma price target raised to $33 from $20 at Roth Capital
1M ago
NVCT
Nuvectis Pharma Announces Major Public Equity Offering
PremiumCompany Announcements
Nuvectis Pharma Announces Major Public Equity Offering
1M ago
8K
NVCT
Midday Fly By: Patrick to combine with LCI, AeroVironment reports Q4 beat
PremiumThe Fly
Midday Fly By: Patrick to combine with LCI, AeroVironment reports Q4 beat
1M ago
BX
GS
Nuvectis Pharma 5M share Spot Secondary priced at $20.00
PremiumThe FlyNuvectis Pharma 5M share Spot Secondary priced at $20.00
1M ago
NVCT
Closing Bell Movers: AeroVironment jumps after quarterly report
Premium
The Fly
Closing Bell Movers: AeroVironment jumps after quarterly report
1M ago
TW
AVAV
Nuvectis Pharma TBA Spot Secondary; price range $20.00-$22.00
Premium
The Fly
Nuvectis Pharma TBA Spot Secondary; price range $20.00-$22.00
1M ago
NVCT
Nuvectis Pharma Suspends Equity Offering Program Under Agreement
PremiumCompany Announcements
Nuvectis Pharma Suspends Equity Offering Program Under Agreement
1M ago
8K
NVCT
Nuvectis Pharma announces common stock offering, no amount given
PremiumThe Fly
Nuvectis Pharma announces common stock offering, no amount given
1M ago
NVCT
Nuvectis Pharma Expands Portfolio with Haisco License Deal
PremiumCompany Announcements
Nuvectis Pharma Expands Portfolio with Haisco License Deal
2M ago
8K
NVCT
Nuvectis Pharma price target raised to $22 from $18 at Lucid Capital
PremiumThe Fly
Nuvectis Pharma price target raised to $22 from $18 at Lucid Capital
2M ago
NVCT
Nuvectis Pharma price target raised to $39 from $13 at H.C. Wainwright
PremiumThe FlyNuvectis Pharma price target raised to $39 from $13 at H.C. Wainwright
2M ago
NVCT
Nuvectis Lands Major Haisco Deal for Two Potentially Best-in-Class Compounds in Multi-Billion-Dollar Markets
Premium
TipRanks Newswire
Nuvectis Lands Major Haisco Deal for Two Potentially Best-in-Class Compounds in Multi-Billion-Dollar Markets
2M ago
ALMS
NVCT
Nuvectis Pharma announces license agreement with Haisco for two compounds
Premium
The Fly
Nuvectis Pharma announces license agreement with Haisco for two compounds
2M ago
NVCT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >